NCT02655185

Brief Summary

The purpose of this study is to determine whether lipid levels are related with incidence of atrial fibrillation in Patients with chronic heart failure.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2016

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 13, 2016

Completed
19 days until next milestone

Study Start

First participant enrolled

February 1, 2016

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

January 13, 2016

Status Verified

January 1, 2016

Enrollment Period

2.4 years

First QC Date

January 10, 2016

Last Update Submit

January 11, 2016

Conditions

Heart Failure

Keywords

LipidsAtrial FibrillationHeart Failure

Outcome Measures

Primary Outcomes (1)

  • Number of participants with newly emerging atrial fibrillation as assessed by electrocardiogram

    three years

Secondary Outcomes (3)

  • Cardiovascular mortality

    three years

  • Worsing heart failure assessed by decreased NYHA class and left ventricular ejection fraction

    three years

  • rate of rehospitalization

    three years

Study Arms (1)

Heart failure

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

In-hospital patients with a diagnosis of chronic heart failure will be recruited at Yangzhou No.1 people's hospital, China.

You may qualify if:

  • Clinical diagnosis of chronic heart failure

You may not qualify if:

  • Use of statins

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart FailureAtrial Fibrillation

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Chen - Liu, MD

    Yangzhou No.1 People's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Chen - Liu, MD

CONTACT

+86-13301457671liuchen007@163.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

January 10, 2016

First Posted

January 13, 2016

Study Start

February 1, 2016

Primary Completion

July 1, 2018

Study Completion

July 1, 2019

Last Updated

January 13, 2016

Record last verified: 2016-01

Data Sharing

IPD Sharing
Will not share